Novartis touts PhIII COPD data; J&J scouts new drug deals in China;

 @FierceBiotech: BASi trims lab costs to recoup losses from first half of 2012. More | Follow @FierceBiotech

 @RyanMFierce: I'm doing some de-stealthing of my own today: Startup Knode takes off with pharma fuel. Report | Follow @RyanMFierce

 @JohnCFierce: Fighting the double chin, one injection at a time: Kythera files $86M IPO to support fat-busting drug. Article | Follow @JohnCFierce

> Novartis ($NVS) has reaped more positive data for its COPD drug NVA237. The treatment is up for review in Europe and slated for FDA review in 2014. Story

> J&J's ($JNJ) dealmakers are focused on China, where the pharma giant is looking for more pacts on cancer drugs, immunology, mental health treatments and more. Story

> India's Sterling Biotech failed to make a scheduled $184 million payment on convertible notes. Story

Pharma News

 @FiercePharma: More on J&J's Zytiga in men with early prostate cancer. Pre-surgery, drug blasted tumors in 1/3 of patients. Story | Follow @FiercePharma

> Another one bites the dust: Plavix falls off patent today. News

> Pfizer's targeted drug knocks out child cancers in small study. Article

> Study links Z-Pak with risk of sudden death. Item

> Top 10 Best-selling Cancer Drugs in 2011. Special Report

Medical Device News

 @FierceMedDev: Folks, the clock is still ticking. Get your nominations in for the 15 fiercest device developers. Survey | Follow @FierceMedDev

> Department of Homeland Security issues device hacking warning. Report

> BrainGate chip enables 2 tetraplegics to control robotic arms. Article

> Former exec indicted, accused of selling adulterated devices. More

> FCC to set aside bandwidth for wireless medical devices. Item

Pharma Manufacturing News

 @EricPFierce: U.K. comes down on regulators for letting defective PIP breast implants through. The FDA had cited the company in 2000. Report | Follow @EricPFierce

> End is near for Watson distribution center. Story

> Pfizer making deep cuts at estrogen extraction plant. Article

> Bristol-Myers starts Orencia manufacturing at new plant. More

> Hikma discloses FDA warning letter. Item

CRO News

 @NesaNFierce: Clinical and pharma controversy in India hasn't scared off Quanticate. Article | Follow @NesaNFierce

> Home drug delivery considered a 'key initiative' for Marken. News

> Covance's AZ lab closure to result in 130 lost jobs. Story

> BASi trims lab costs to recoup losses from first half of 2012. More

> Patient recruitment should be a greater priority, drugmakers say in survey. Item

Vaccines News

> Inovio makes steps towards a universal flu vax. Report

> Biovest makes a move on the EU market with BiovaxID. Article

> Nasal HIV vax safe, triggers immune response. News

> Researchers engineer edible malaria vaccine. Story

And Finally… A new study provides fresh evidence that coffee is one of the healthier elixirs on the market, offering a modest health benefit for java lovers. Story

 

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.